Therapy News and Research

RSS
Unlocking sulfasalazine's mechanism of action in IBD-SpA patients

Unlocking sulfasalazine's mechanism of action in IBD-SpA patients

Aging alters fibroblasts to promote pancreatic cancer growth

Aging alters fibroblasts to promote pancreatic cancer growth

Investigating dosage in hyperbaric oxygen therapy for post-covid conditions

Investigating dosage in hyperbaric oxygen therapy for post-covid conditions

Novel therapy harnesses stem cell-derived exosomes for diabetic wound healing

Novel therapy harnesses stem cell-derived exosomes for diabetic wound healing

Study proposes novel approach to slow neuromuscular degeneration in ALS patients

Study proposes novel approach to slow neuromuscular degeneration in ALS patients

Breakthrough gene therapy method utilizes bird retrotransposon for safe gene insertion

Breakthrough gene therapy method utilizes bird retrotransposon for safe gene insertion

MIP Discovery closes £7M Series A financing to drive commercialization in cell and gene therapy space

MIP Discovery closes £7M Series A financing to drive commercialization in cell and gene therapy space

Researchers develop novel nanomedicine loaded with genetic material to fight  HIV

Researchers develop novel nanomedicine loaded with genetic material to fight HIV

Increased risk of autoimmune disease after Cushing's disease remission

Increased risk of autoimmune disease after Cushing's disease remission

Sleep-circadian disturbances can trigger or worsen a range of psychiatric disorders

Sleep-circadian disturbances can trigger or worsen a range of psychiatric disorders

New RNA therapy zilebesiran shows promise in lowering blood pressure

New RNA therapy zilebesiran shows promise in lowering blood pressure

What factors are associated with recent prostate-specific antigen screening in transgender women?

What factors are associated with recent prostate-specific antigen screening in transgender women?

Single-dose genetic medicine halts the progression of ALS and frontotemporal dementia in mice

Single-dose genetic medicine halts the progression of ALS and frontotemporal dementia in mice

FDA approves omalizumab for food allergy reactions based on NIH research

FDA approves omalizumab for food allergy reactions based on NIH research

Innovative immunotherapy targets rare melanoma subtypes

Innovative immunotherapy targets rare melanoma subtypes

Neoadjuvant chemotherapy shows promise for advanced penile cancer

Neoadjuvant chemotherapy shows promise for advanced penile cancer

Study suggests patients with severe long COVID present with variable symptoms, do not cluster in relation to organs affected or immunological states

Study suggests patients with severe long COVID present with variable symptoms, do not cluster in relation to organs affected or immunological states

Exercise is an effective treatment for depression, with walking, jogging, yoga, and strength training more effective than other exercises

Exercise is an effective treatment for depression, with walking, jogging, yoga, and strength training more effective than other exercises

Study suggests CT imaging with automated AI system predicts EGFR genotype, identifying mutation status cost-effectively and non-invasively

Study suggests CT imaging with automated AI system predicts EGFR genotype, identifying mutation status cost-effectively and non-invasively

Transforming Cancer Care: Aventa Genomics and the Future of Genomic Testing

Transforming Cancer Care: Aventa Genomics and the Future of Genomic Testing

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.